chloroquine has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 1 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hounjet, J | 1 |
| Habets, R | 1 |
| Schaaf, MB | 1 |
| Hendrickx, TC | 1 |
| Barbeau, LMO | 1 |
| Yahyanejad, S | 1 |
| Rouschop, KM | 1 |
| Groot, AJ | 1 |
| Vooijs, M | 1 |
1 other study available for chloroquine and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
The anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to γ-secretase inhibition.
Topics: Amyloid Precursor Protein Secretases; Antimalarials; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell P | 2019 |